osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'aura ,(-laura)']
 #plenarysession update on #adaura from #asco23 [os]imertinib benefit strong hr 0.49 for stages ib iiia 5 yr os rates of 88% w/ osi v 78% w/ placebo #lcsm 
Thoracic Medical Oncologist, Assistant Professor @MDAndersonNews | Interested in patient education, PROs, personalized care | 🫁#cancer #lcsm | Views are my own